Educational activities

COORDINATOR

Prof. Dr. Anna Licata, MD

COORDINATOR

Dr. Vanesa Garrido Rodríguez

COORDINATOR

Prof. Dr. Jane Grove

YOUNG INVESTIGATORS AFTERWORKS SERIESCOORDINATOR

Prof. Ann Daly

Monthly International Seminar Series on Liver Toxicity and Steatotic Liver Disease and different EASL studio topics for DHILI will be organised at a later stage.

As a proposal within our educational activities, we will be launching from January a series of talks on Liver Toxicity and Steatotic Liver Disease, ONCE monthly, given by international experts in the field. The session outline would be a talk of around 45 min with 15 min left for discussion. Conferences will be held on the 3rd Wednesday of each month at 16.30h (CET) starting from January 17th 2024.

These international seminar series are the result of an outstanding collaboration between the EASL DHILI Consortium (https://easldhiliconsortium.eu/) and the Halt-RONIN (UKRI-Horizon Europe) https://halt-ronin.com/

The objectives are:

  • to improve collaboration between different group experts encompassing clinical investigators, researchers, basic scientists, industry partners and regulators.
  • To foster scientific progress by disseminating the latest breakthroughs in research on hepatotoxicity and metabolic dysfunction-associated steatotic liver disease

This study uses mass cytometry to characterise the circulating immune profile of acute DILI and compare it with autoimmune hepatitis, viral hepatitis, and idiopathic acute liver injury. We identify coordinated changes across innate and adaptive immunity, with both shared and disease-specific features. We also assess their longitudinal evolution and explore multiparametric immune signatures with potential to support DILI classification.

About the speaker Dr. Daniel Di Zeo Sánchez holds a degree in Biochemistry, a Master’s degree in Advanced Biotechnology, and a PhD in Biomedicine with International Mention from the University of Málaga. He has over eight years of research experience, mainly at IBIMA Plataforma BIONAND, in the fields of hepatology and pharmacology. His research focuses on the immune and metabolic mechanisms underlying liver diseases, particularly drug-induced liver injury. He has participated in 14 national and international research projects, authored 14 peer-reviewed scientific publications, and presented more than 40 communications at national and international conferences. He is a member of CIBEREHD and participates in international scientific networks such as the EASL DHILI Consortium. His career also includes an international research stay (Short-Term Scientific Mission) at iMED in Lisbon, and he currently combines biomedical research with university teaching.